SEARCH HEALTH CONDITIONS BY ALPHABETS
CAPS (Cryopyrin-Associated Periodic Syndromes)
Medications for Cryopyrin-Associated Periodic Syndromes
Other names: CAPS
About Cryopyrin-Associated Periodic Syndromes: Cryopyrin-Associated Periodic Syndromes are a set of rare autosomal dominant diseases, generally due to mutations affecting the cryopryin protein. Included within this class are Familial cold autoinflammatory syndrome, Muckle-Wells syndrome and Neonatal-onset multisystem inflammatory infantile neurological.
Drugs Used to Heal Cryopyrin-Associated Periodic Syndromes
This listing of medications are somehow related to, or used at the treating this condition.
| Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Kineret | Rx | B | N | Insert review | 0.0 | ||
Generic title: anakinra systemic Drug category: Anti-rheumatics, interleukin inhibitors For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Arcalyst | Rx | C | N | Insert review | 0.0 | ||
Generic title: rilonacept systemic Medication course: interleukin inhibitors For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Ilaris | Rx | C | N | Insert review | 0.0 | ||
Generic title: canakinumab systemic Medication course: interleukin inhibitors For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| rilonacept | Rx | C | N | Insert review | 0.0 | ||
Generic title: rilonacept systemic Brand title: Arcalyst Medication course: interleukin inhibitors For consumers: dosage, interactions, For professionals: Az Drug Truth, AHFS DI Monograph | |||||||
| anakinra | Rx | B | N | Insert review | 0.0 | ||
Generic title: anakinra systemic Brand title: Kineret Drug category: Anti-rheumatics, interleukin inhibitors For consumers: dosage, interactions, For professionals: Az Drug Truth, AHFS DI Monograph | |||||||
| canakinumab | Rx | C | N | Insert review | 0.0 | ||
Generic title: canakinumab systemic Brand title: Ilaris Medication course: interleukin inhibitors For consumers: dosage, interactions, For professionals: az Drug Truth, AHFS DI Monograph | |||||||
Topics under Cryopyrin-Associated Periodic Syndromes
- Familial Cold Autoinflammatory Syndrome (4 medication )
- Muckle-Wells Infection (4 medication )
Legend
| Rx | Prescription Only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Prizes | This drug may not be accepted by the FDA for the treatment of this condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in elderly women. |
| C | Animal reproduction studies have demonstrated an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in elderly women obviously outweigh potential rewards. |
| N | FDA has not classified this drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | isn`t subject to the Controlled Substances Act. |
| Inch | features a higher possibility of misuse. Has no currently accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision. |
| Two | features a higher possibility of misuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Psychotherapy can result in severe psychological or physical dependency. |
| 3 | Has a potential for abuse less than those in programs 1 and two. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to physical dependence or high psychological dependence. |
| 4 | features a low potential for abuse relative to those in program 3. It`s a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence. |
| 5 | features a low potential for abuse relative to those in program 4. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always consult your healthcare provider to make sure the information applies to a circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
